Navigation Links
Changes in amino acids in the 1918 influenza virus cut transmission

rough an alpha-2,6 bond and another is through an alpha-2,3 bond. Hemagglutinins from avian influenza virus prefer binding to alpha 2-3 sialic acids, while hemagglutinins from human influenza viruses prefer binding to alpha 2-6 sialic acids, which are highly abundant in the upper respiratory tract of humans. For an avian virus to be able to jump to humans and to start a new pandemic, it has been hypothesized that the hemagglutinin needs to mutate and change its binding preference from alpha2-3 to alpha2-6 sialic acids.

In this study, the researchers used ferrets as an animal model of human influenza virus infection, due to the presence of alpha2-6 sialic acids in the respiratory tract of ferrets, similar to the human scenario. Groups of ferrets were infected with three types of influenza viruses; two from existing viral strains related to the 1918 flu and taken from human tissue, and the third, which was artificially created in a laboratory and made to look like avian flu. One virus bound to only alpha-2,6, the second bound to both, and the artificially-generated virus bound to only alpha-2,3.

The researchers were surprised to discover that the ferrets infected with all three viruses, including the one with preference for binding to alpha2-3 sialic acids, experienced severe disease, with high levels of virus replication in the respiratory tract. However, only the virus with specificity for binding to alpha2-6 silaic acids was able to transmit by aerosols to contact ferrets. "It appears that when the virus only had an alpha-2,3 binding activity, replication and virulence didn't change," explains Dr. GarcĂ­a-Sastre. "These animals still had symptoms, however transmission was practically abolished." Since the artificially-generated virus featured alpha-2,3 sialic acid binding activity, this finding indicated that alpha-2,6 sialic acid binding activity was more important for optimal viral transmission. "Our findings indicate that, to become more
'"/>

Source:The Mount Sinai Hospital / Mount Sinai School of Medicine


Page: 1 2 3

Related biology news :

1. Iron Deficiency Sparks Dramatic Changes In Gene Expression
2. Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower
3. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
4. Methamphetamine Abuse, HIV Infection Cause Changes in Brain Structure
5. Changes to embryos can elicit change in adult fish
6. Conserved amino acids play both structural and mechanistic roles in sandwich-like protein
7. New technique helps researchers determine amino-acid charge
8. Use of amino acid supplement following a heart attack provides no benefit, may be harmful
9. Amino acids in nectar enhance butterfly fecundity: A long awaited link
10. Researchers create pigs that produce heart-healthy omega-3 fatty acids
11. Computers to be used to find blueprint for new influenza drug

Post Your Comments:
(Date:11/24/2009)...ch Institute (LRI) today named 12 new grant recipi...recognize innovative work across a broad spectrum ...ativity, novelty, and potential to drive scientifi... the complex disease of systemic lupus. , The 20...earchers across the nation and include interdiscip...
(Date:11/24/2009)... weakened and flabby arteries from collapsing have...e stents are no longer needed -- once the arteries...usly, doctors had no choice but to leave them in p...rsity,s Department of Biomedical Engineering has d...carries drugs where they,re needed, then dissolves...
(Date:11/24/2009)...NEW YORK (November 24, 2009) -- The Wildlife Conse...ealing that the last remaining population of Siber...o the rising tide of poaching and habitat loss. ,... Russian officials of what needs to be done to pro...cat. , The report was released by t...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2Employment Policies Institute Launches 2410 Million Campaign Urging the Public to Rethink Health Care Reform 61198 1Employment Policies Institute Launches 2410 Million Campaign Urging the Public to Rethink Health Care Reform 61198 2Speedus Corp Names Stephen X Graham to Board of Directors 61195 1Speedus Corp Names Stephen X Graham to Board of Directors 61195 2Memphis Mayor Endorses National Bipolar Foundation 61190 1Memphis Mayor Endorses National Bipolar Foundation 61190 2
... rise in autoimmune diseases such as multiple scle...nvironmental factors could be the cause of this in...esis" in which an excessively germ-free environmen...s that a decline in infectious diseases may play a...The first study examining the relationship between...
...ysis of nicotine yield from major brand name cigar...confirmed that manufacturers have steadily increas...dependent analysis, based on data submitted to the...by the manufacturers, found that increases in smok...t each year, or about 11 percent over a seven-year...
... drugs (opioids) are commonly prescribed for short...tiveness long-term has been questioned in a review..., who also found that behaviors consistent with op... "Patients with chronic back pain commonly request...despite the concerns clinicians have with patients...
Other Biology News:Parasite infection may benefit MS patients 2Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent 2Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent 3
(Date:11/24/2009)... The New York investment bank KTA Capital,s c...eed an AU$6.7 mil convertible note private placeme... placement was arranged by KTA Capital as Neuren,s... New York (PRWEB) November 23, 200...Capital, LLC ("KTA Capital") has announc...
(Date:11/24/2009)...ENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--DowAg...tsofHylandSeeds,adivisionofThompsonsLimitedofBlenh...andDowAgroSciences,currentseedsbusinessasthecompan...10 andDowAgroSciencesHerbicideTolerantTraitTechno...thenearfuture. ,, "Thisacquisitionbringstogethe...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--Sigma-AldrichCorporatio...erenceonTuesday,December1stat1:45PMGMTinLondon,7:4...oadcastovertheInternetavailableat http://inve s ...Webcast"icontoaccessthisfile. ,, AboutSigma-A...Technologycompany.Itschemicalandbiochemicalproduct...
(Date:11/24/2009)...eland,November24/PRNewswire-FirstCall/--deCODE,gen...ofallofits,"firstday"motionsbytheU.S.BankruptcyCou...deCODElastweekfiledavoluntarypetitionfor,reliefund...BankruptcyCourt. , TheordersissuedbytheBankru...inessduringtheChapter11proceedings.Inparticular,th...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...H, N.J., Jan. 9 Schering-Plough Corporation (NYSE...resentation by Thomas P. Koestler, Ph.D., executiv...search Institute, at the 27th Annual J.P. Morgan H...an. 12, at approximately 3:30 p.m. (PST) (6:30 p.m...mpany,s R&D pipeline and select projects in de...
...RD, Pa., Jan. 9 Endo Pharmaceuticals (Nasdaq: E...t and Chief Executive Officer of Endo, will presen...l Healthcare Conference on Wednesday, January 14, ...ill be held January 12-15, 2009 in San Francisco. ...tation may be accessed on the Endo Website at www...
...N, Ireland, January 9 Azur Pharma Limited ("Azur,...usive U.S. marketing rights,for Niravam(R) (alpraz...arbidopa-levodopa orally disintegrating tablets), ...s) and Fluxid(TM) (famotidine orally,disintegratin...ms were not,disclosed. , Niravam, Parcopa and ...
Other Biology Technology:Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference 2Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB 2
Rat Anti-karyopherin alpha2 Monoclonal Antibody, Unconjugated, Clone 2G7 from Santa Cruz Biotechnology, Inc.
Goat Anti-TNF-R2 (L-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Cytosol/Particulate Separation Kit from BioVision
MitoCapture Apoptosis Detection Kit from BioVision
Biology Products: